Bud Genius in Stock Buyback Talks
September 03 2014 - 8:37AM
Business Wire
The Board of Directors of Rightsmile Inc., which is soon to be
called Bud Genius Inc. (Symbol: RIGH), yesterday declared that it
is in talks regarding a buyback of its common stock.
The decision was influenced by company expansion by its new
subsidiary, Genius Biotech Corporation, which may be listed on the
OTC:BB complete with a registration.
Company CEO, Angel Stanz, provided the following quote: “The
number of outstanding shares needs to be reduced. All stock
buybacks will be followed by a corresponding reduction in the
number of authorized shares as well. We felt it would be cheaper to
do this now, before our new subsidiary has grown. We have disclosed
that we are considering an OTC:BB listing for the company, so this
is an opportune time for us to concentrate shareholder value. By
now I have my eye on a few pieces of stock that I would like to
reclaim. Any buybacks may vary in size, and we can’t negotiate
everything at once, but that’s okay because it can really pay off
in the long run. By doing this, we are putting our money where our
mouth is, because we are in this for the long-term growth.”
About Bud Genius
An early leader in an industry that many are speculating will
grow, Bud Genius is one of the first established analytical
cannabis laboratories in the United States. Bud Genius was launched
to bring vendors together with doctors, patients, and dispensaries
that require certified products held to demanding standards. Bud
Genius has a vision to expand across the US and abroad serving as
the beacon of quality for medical cannabis and adult-use marijuana
through the formation of regional laboratories. Certification, data
collection, and online reports are the measure by which the company
gains.
For more information please visit: http://www.BudGenius.com
The foregoing press announcement contains forward-looking
statements that can be identified by such terminology such as
"believes," "expects," "potential," "plans," "suggests," "may,"
"should," "could," "intends," or similar expressions. Such
forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results
to be materially different from any future results, performance or
achievements expressed or implied by such statements. In
particular, management's expectations could be affected by, among
other things, uncertainties relating to our success in completing
acquisitions, financing our operations, entering into strategic
partnerships, engaging management and other matters disclosed by us
in our public filings from time to time. Forward-looking statements
speak only as to the date they are made. The Company does not
undertake to update forward-looking statements to reflect
circumstances or events that occur after the date the
forward-looking statements are made.
Bud GeniusAngel Stanz, 855-723-3283Chief Executive
OfficerPR@BudGenius.com
RightSmile (CE) (USOTC:RIGH)
Historical Stock Chart
From Mar 2024 to Apr 2024
RightSmile (CE) (USOTC:RIGH)
Historical Stock Chart
From Apr 2023 to Apr 2024